# CORRESP — Enveric Biosciences, Inc.  (ENVB)  (CIK 0000890821)

> <strong>Enveric Biosciences, Inc.  (ENVB)  (CIK 0000890821) → SEC staff</strong> · filed 2026-04-28 · ticker ENVB · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-019272
- **Form:** CORRESP
- **Filer:** Enveric Biosciences, Inc.  (ENVB)  (CIK 0000890821)
- **CIK:** 0000890821
- **Ticker:** ENVB
- **Filed:** 2026-04-28
- **SIC industry:** 2834
- **HQ:** Cambridge, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/890821/000149315226019272/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=890821&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Enveric Biosciences, Inc.  (ENVB)  (CIK 0000890821)

- UPLOAD — 2026-04-27 — /comment-letter/0000000000-26-004265
- CORRESP — 2025-12-08 — /comment-letter/0001493152-25-026563
- UPLOAD — 2025-09-30 — /comment-letter/0000000000-25-010725

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Enveric Biosciences, Inc.  (ENVB)  (CIK 0000890821) (CIK 0000890821), filed 2026-04-28, accession 0001493152-26-019272. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001493152-26-019272.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*